# clm_26C5F13E4AFA

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: total_equity  
value: 1,021,546,000 United States dollar  
valid_from: 2016-09-30  
valid_to: 2016-12-31  
published: 2016-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A595BC2C5630  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals total equity: 1,021,546,000 United States dollar", as of 2016-09-30 (until 2016-12-31). Claim clm_26C5F13E4AFA, https://asof.is/claim/clm_26C5F13E4AFA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532016000107/0000875320-16-000107-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532016000107/0000875320-16-000107-index.htm (primary, SEC EDGAR 10-Q Q3 FY2016, published 2016-10-31)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | total_equity | 981,354,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_26C5F13E4AFA](/claim/clm_26C5F13E4AFA.md) | [clm_E3F59624DB5A](/claim/clm_E3F59624DB5A.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.